首页> 外文期刊>Expert opinion on therapeutic targets >The potential for phospholipase D as a new therapeutic target.
【24h】

The potential for phospholipase D as a new therapeutic target.

机译:磷脂酶D作为新治疗靶标的潜力。

获取原文
获取原文并翻译 | 示例
           

摘要

Mammalian phospholipase D (PLD), a signal transduction-activated enzyme, hydrolyzes phosphatidylcholine to generate the lipid second messenger phosphatidic acid (PA) and choline. Genetic and pharmacological methods have implicated PLD and its product PA in a wide variety of cellular processes including vesicle trafficking, receptor signaling, cell proliferation and survival. Dysregulation of these cell biologic processes occurs in a diverse range of illnesses including cancer. This review summarizes PLD regulation and function and highlights its potential as a therapeutic target in disease settings.
机译:哺乳动物磷脂酶D(PLD)是一种信号转导激活的酶,可水解磷脂酰胆碱以生成脂质第二信使磷脂酸(PA)和胆碱。遗传和药理学方法已将PLD及其产物PA牵涉到多种细胞过程中,包括囊泡运输,受体信号传导,细胞增殖和存活。这些细胞生物学过程的失调发生在包括癌症在内的多种疾病中。这篇综述总结了PLD的调节和功能,并着重指出了其在疾病环境中作为治疗靶标的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号